Perioperative intravenous immunoglobulin treatment in a patient with severe acquired von Willebrand syndrome: case report and review of the literature
- PMID: 28469872
- PMCID: PMC5412814
- DOI: 10.1002/ccr3.890
Perioperative intravenous immunoglobulin treatment in a patient with severe acquired von Willebrand syndrome: case report and review of the literature
Abstract
Acquired von Willebrand syndrome may be related to plasma cell dyscrasia and can cause severe bleeding complications. Treatment, for example, with intravenous immunoglobulins may be indicated in selected cases. Physicians treating plasma cell dyscrasia have to be aware of bleeding complications in these patients, and clarification is necessary.
Keywords: Acquired von Willebrand syndrome; bleeding; intravenous immunoglobulins; monoclonal gammopathy of undetermined significance; multimer analysis.
Figures
References
-
- Simone, J. V. , Cornet J. A., and Abildgaard C. F.. 1968. Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood 31:806–812. - PubMed
-
- International Registry on Acquired Von Willebrand Syndrome, http://www.intreavws.com
-
- Federici, A. B. , Budde U., and Rand J. H.. 2004. Acquired von Willebrand syndrome 2004: International Registry–diagnosis and management from online to bedside. Hamostaseologie 24:50–55. - PubMed
-
- Tiede, A. 2012. Diagnosis and treatment of acquired von Willebrand syndrome. Thromb. Res. 130(Suppl. 2):S2–S6. - PubMed
-
- Arslan, M. T. , Ozyurek R., Kavakli K., Levent E., Ulger Z., Gurses D., et al. 2007. Frequency of acquired von Willebrand's disease in children with congenital heart disease. Acta Cardiol. 62:403–408. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
